Cargando…

Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners

BACKGROUND: Cognitive problems are a common and debilitating symptom of multiple sclerosis (MS). Screening and treatment for cognitive problems are recommended, however these are not routinely delivered in UK clinics. We collected and synthesised stakeholder perspectives to develop a care pathway fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Laura, Elwick, Hannah, Mhizha-Murira, Jacqueline R., Topcu, Gogem, Bale, Clare, Evangelou, Nikos, Timmons, Stephen, Leighton, Paul, das Nair, Roshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B. V 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533050/
https://www.ncbi.nlm.nih.gov/pubmed/33677366
http://dx.doi.org/10.1016/j.msard.2020.102563
_version_ 1783590053825478656
author Smith, Laura
Elwick, Hannah
Mhizha-Murira, Jacqueline R.
Topcu, Gogem
Bale, Clare
Evangelou, Nikos
Timmons, Stephen
Leighton, Paul
das Nair, Roshan
author_facet Smith, Laura
Elwick, Hannah
Mhizha-Murira, Jacqueline R.
Topcu, Gogem
Bale, Clare
Evangelou, Nikos
Timmons, Stephen
Leighton, Paul
das Nair, Roshan
author_sort Smith, Laura
collection PubMed
description BACKGROUND: Cognitive problems are a common and debilitating symptom of multiple sclerosis (MS). Screening and treatment for cognitive problems are recommended, however these are not routinely delivered in UK clinics. We collected and synthesised stakeholder perspectives to develop a care pathway for cognitive problems in MS and produce a logic model, illustrating how this pathway might operate. METHODS: Forty-nine stakeholders, including people with MS and care providers, participated in semi-structured interviews and focus groups. Participants viewed information that illustrated how the pathway might work and provided feedback. Data, transcribed verbatim and analysed using Framework Analysis, were mapped onto a preliminary logic model and accompanying thematic framework. RESULTS: The proposed pathway was perceived as helpful in providing standardised support for a neglected MS symptom. Training packages, online cognitive screening, and triaging decisions were viewed as crucial activities. Shared responsibility, a person-centred approach, and addressing the complexity of cognitive problems were important engagement mechanisms. Allocating time during clinic appointments and within staff workloads were essential resources for implementation. CONCLUSION: Our co-constructed MS cognitive screening and management pathway will be evaluated for clinical and cost-effectiveness in a trial. However, in the interim, clinicians can adapt and implement this pathway in their own services and evaluate it locally.
format Online
Article
Text
id pubmed-7533050
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier B. V
record_format MEDLINE/PubMed
spelling pubmed-75330502020-10-05 Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners Smith, Laura Elwick, Hannah Mhizha-Murira, Jacqueline R. Topcu, Gogem Bale, Clare Evangelou, Nikos Timmons, Stephen Leighton, Paul das Nair, Roshan Mult Scler Relat Disord Original Article BACKGROUND: Cognitive problems are a common and debilitating symptom of multiple sclerosis (MS). Screening and treatment for cognitive problems are recommended, however these are not routinely delivered in UK clinics. We collected and synthesised stakeholder perspectives to develop a care pathway for cognitive problems in MS and produce a logic model, illustrating how this pathway might operate. METHODS: Forty-nine stakeholders, including people with MS and care providers, participated in semi-structured interviews and focus groups. Participants viewed information that illustrated how the pathway might work and provided feedback. Data, transcribed verbatim and analysed using Framework Analysis, were mapped onto a preliminary logic model and accompanying thematic framework. RESULTS: The proposed pathway was perceived as helpful in providing standardised support for a neglected MS symptom. Training packages, online cognitive screening, and triaging decisions were viewed as crucial activities. Shared responsibility, a person-centred approach, and addressing the complexity of cognitive problems were important engagement mechanisms. Allocating time during clinic appointments and within staff workloads were essential resources for implementation. CONCLUSION: Our co-constructed MS cognitive screening and management pathway will be evaluated for clinical and cost-effectiveness in a trial. However, in the interim, clinicians can adapt and implement this pathway in their own services and evaluate it locally. Elsevier B. V 2021-04 /pmc/articles/PMC7533050/ /pubmed/33677366 http://dx.doi.org/10.1016/j.msard.2020.102563 Text en © 2020 The Authors. Published by Elsevier B.V. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Smith, Laura
Elwick, Hannah
Mhizha-Murira, Jacqueline R.
Topcu, Gogem
Bale, Clare
Evangelou, Nikos
Timmons, Stephen
Leighton, Paul
das Nair, Roshan
Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
title Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
title_full Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
title_fullStr Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
title_full_unstemmed Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
title_short Developing a clinical pathway to identify and manage cognitive problems in Multiple Sclerosis: Qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
title_sort developing a clinical pathway to identify and manage cognitive problems in multiple sclerosis: qualitative findings from patients, family members, charity volunteers, clinicians and healthcare commissioners
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533050/
https://www.ncbi.nlm.nih.gov/pubmed/33677366
http://dx.doi.org/10.1016/j.msard.2020.102563
work_keys_str_mv AT smithlaura developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT elwickhannah developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT mhizhamurirajacqueliner developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT topcugogem developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT baleclare developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT evangelounikos developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT timmonsstephen developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT leightonpaul developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT dasnairroshan developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners
AT developingaclinicalpathwaytoidentifyandmanagecognitiveproblemsinmultiplesclerosisqualitativefindingsfrompatientsfamilymemberscharityvolunteerscliniciansandhealthcarecommissioners